| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.110 | 36.226 | 48.644 | 31.874 | 36.930 | 40.892 | 38.117 | 29.597 | 34.770 | 34.403 |
| Total Income - EUR | 61.032 | 44.522 | 50.188 | 44.753 | 51.362 | 45.153 | 38.377 | 32.889 | 35.314 | 34.565 |
| Total Expenses - EUR | 51.631 | 41.770 | 48.548 | 43.206 | 49.606 | 44.198 | 35.206 | 28.854 | 34.884 | 36.859 |
| Gross Profit/Loss - EUR | 9.401 | 2.752 | 1.641 | 1.547 | 1.756 | 954 | 3.172 | 4.035 | 430 | -2.294 |
| Net Profit/Loss - EUR | 9.167 | 1.877 | 906 | 1.102 | 1.244 | 526 | 2.129 | 3.382 | 135 | -2.604 |
| Employees | 1 | 1 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biyovis Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.218 | 21.802 | 17.372 | 13.066 | 11.421 | 9.007 | 9.702 | 7.952 | 6.583 | 5.478 |
| Current Assets | 34.761 | 29.516 | 30.852 | 23.905 | 23.024 | 20.418 | 18.002 | 20.973 | 20.694 | 18.421 |
| Inventories | 19.303 | 22.465 | 18.055 | 18.235 | 15.699 | 12.573 | 11.446 | 14.342 | 14.704 | 12.541 |
| Receivables | 14.284 | 6.944 | 11.828 | 7.265 | 7.020 | 6.488 | 5.638 | 6.453 | 4.824 | 3.911 |
| Cash | 1.173 | 107 | 969 | -1.594 | 304 | 1.357 | 918 | 177 | 1.166 | 1.969 |
| Shareholders Funds | -52 | 1.892 | 2.765 | 3.817 | 4.986 | 5.418 | 7.427 | 10.832 | 10.935 | 8.269 |
| Social Capital | 45 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 56.031 | 49.428 | 44.490 | 32.700 | 29.458 | 24.008 | 20.277 | 18.092 | 16.343 | 15.630 |
| Income in Advance | 0 | -128 | 968 | 454 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Biyovis Company Srl